KATHERINE HARVELL: Open Payments
NPI 1689909236 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 66 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $908 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $262 |
| ABBVIE INC. | 8 | $231 |
| Novo Nordisk Inc | 7 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $165 |
| Amgen Inc. | 10 | $159 |
| PFIZER INC. | 9 | $153 |
| Boston Scientific Corporation | 3 | $84 |
| IDORSIA PHARMACEUTICALS US INC | 3 | $72 |
| Lilly USA, LLC | 3 | $57 |
| Exact Sciences Corporation | 2 | $54 |
Products named: CAPLYTA, VRAYLAR, Kerendia, Wegovy, NURTEC ODT, OTEZLA, General - Pain Management, Quviviq.
Industry payments across GA — which companies pay providers there.
